Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease (Q28345937)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

3

P Rutgeerts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Jean-Frederic Colombel

2

object named as

J F Colombel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

K Lauritsen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

H Malchow

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Hämling

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Winter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Van Gossum A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Persson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E Pettersson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

186-190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

3 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728198

The MOS 36-ltem Short-Form Health Survey (SF-36)

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728198

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728198

Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728198

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728198

Frequency of glucocorticoid resistance and dependency in Crohn's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728198

National Cooperative Crohn's Disease Study: results of drug treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728198

Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma

29 September 2017

1 reference

12 December 2020

A new measure of health status for clinical trials in inflammatory bowel disease

1 reference

12 December 2020

Medical management of Crohn's disease

1 reference

12 December 2020

A comparison of budesonide with prednisolone for active Crohn's disease

1 reference

12 December 2020

Methotrexate for the Treatment of Crohn's Disease

1 reference

12 December 2020

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

12 December 2020

Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group

1 reference

12 December 2020

Medical therapy of inflammatory bowel disease

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.48.2.186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156638%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference